Author:
Bujar Magdalena,Donelan Ronan,McAuslane Neil,Walker Stuart,Salek Sam
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference26 articles.
1. Liberti L, McAuslane N, Patel P, Breckenridge A, Eichler HG, Peterson R. Regulatory review: how do agencies ensure the quality of decision making? Clin Pharmacol Ther. 2013;94:305–308.
2. Pinatti F, Ashby D, Brass E, et al. Structured frameworks to increase the transparency of the assessment of benefits and risks of medicines: current status and possible future directions. Clin Pharmacol Ther. 2015;98:522–533.
3. WHO Technical Report Series, No. 992, Annex 9;World Health Organization,2015
4. Patel P, McAuslane N, Liberti L, Connelly P. Workshop report: Focus on Latin America; Building quality submission and review processes and practices—Overcoming challenges and meeting expectations. Centre for Innovation in Regulatory Science. http://cirsci.org/sites/default/files/CIRS_January_2014_Workshop_Report.pdf. Accessed May 19, 2016.
5. Cook D, Brown D, Alexander R, et al. Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov. 2014;13:419–431.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献